The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
A Guide to Benzodiazepine Selection. Part I: Pharmacological Aspects *
Abstract
Since absorption rates, volumes of distribution and elimination rates differ greatly among the benzodiazepine derivatives, each benzodiazepine has a unique plasma concentration curve. Although the time to peak plasma levels provides a rough guide, it is not equivalent to the time to clinical onset of effect. Two half-lives can be described: the alpha half-life, the rate of decline in plasma concentrations due to the process of drug redistribution from the central to the peripheral compartment, and the beta half-life, the rate of decline due to the process of drug elimination due to metabolism. The frequent classification of benzodiazepines into long, intermediate, and short-“acting” categories based on their terminal beta half-lives is unfounded; the duration of action is much more dependent on the alpha half-life. Benzodiazepines with short beta half-lives are commonly thought to be preferable because they accumulate less. However, with repeated use, sedation and cognitive neuromotor impairment usually diminish progressively despite stable or even rising benzodiazepine plasma concentrations, whereas anxiolytic effects generally persist over time.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Length of treatment and high potency with short to intermediate elimination half-life seem important to favor the occurrence of persistent post-withdrawal disorders [41].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [41]
In the citing paper
“and in some cases they persist for years [41].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [41]
In the citing paper
“Notwithstanding this, anxiety, depression, psychosis, cognitive impairment, insomnia, sensory phenomena (i.e., tinnitus, tingling, numbness, paresthesia, deep or burning pain in limbs, feeling of inner trembling or vibration, strange skin sensations), motor phenomena (i.e., muscle pain, weakness, painful cramps, tremor, jerks, spasms, shaking attacks), and gastrointestinal disturbances (pat”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [41]
Citations
Cites
Psychopharmacology: The third generation of progress
O'Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,013 · cited 1×
“One explanation for the difference in pharmacodynamic profiles of various benzodiazepine derivatives involves binding to different subclasses of benzodiazepine receptors (8,24-26).”
BackgroundBenzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700 · cited 1×
“The potency of a benzodiazepine is correlated with its affinity for its binding sites (8,10).”
BackgroundBenzodiazepine receptors in rat brain
SQUIRES, R. F., & BRAESTRUP, C. (1977) · Nature · doi:10.1038/266732a0 · Cited by 1,449
Guidotti, A., Forchetti, C. M., Corda, M. G., Konkel, D., Bennett, C. D., & Costa, E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.11.3531 · Cited by 644 · cited 1×
“Diazepam binding inhibitor (DBI), a naturally occurring peptide which binds to benzodiazepine receptors but inhibits, rather than potentiates, the effects of GABA, was proposed as an endogenous "anxiogenic" ligand (29).”
BackgroundCurrent Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
The amnesic action of benzodiazepines in man
Lister, R. G. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90034-x · Cited by 448 · cited 1×
“These short periods of memory impairment do not appear to be related to non specific sedative effects, but rather to an inability to store new information in long term memory (61).”
BackgroundCurrent Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308113090607 · Cited by 249 · cited 1×
“In fact, fatal overdoses of benzodiazepines alone are almost unheard of (17-20).”
BackgroundTolerance to the behavioral actions of benzodiazepines
File, S. E. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90037-5 · Cited by 205 · cited 4×
“The mechanism of the tolerance has not been clearly explained, but may include changes at the level of the benzodiazepine-GABA receptor complex, such as altered benzodiazepine-GABA coupling (55).”
BackgroundInfluentialAnxiety and depression: a common neurobiological substrate?
Paul, S. M. (1988) · PubMed · Cited by 171
Chemotherapy in psychiatry : principles and practice
Baldessarini, R. J. (1985) · Medical Entomology and Zoology · Cited by 135
Research works printed but not linked: 20
- Busto U., 1986, Acta Pharmacol Toxicol (Copenh), 203
- Haefely W., 1985, Adv Drug Res, 14, 165
- Harvey S.C., 1985, Goodman and Gilman's the pharmacological basis of therapeutics, seventh edition.
- Marks J., 1985, The benzodiazepines: use, overuse, misuse, abuse, second edition.
- Ongini E., 1985, Clin Neuropharmacol, 8, 517
- Enna S.J., 1987, Psychopharmacology: the third generation of progress.
- Stephenson F.A., 1987, TINS, 10, 185
- Greenblatt D.J., 1987, Psychopharmacology, 3, 62
- Greenblatt D.J., 1987, Psychopharmacology: the third generation of progress.
- Jochemsen R., 1984, PHIND, 244
- McEvoy G.K., 1989, American Hospital Formulary Service drug information.
- 1989, Compendium of pharmaceuticals and specialties, twenty-fourth edition.
- Salzman C., 1980, J Clin Psychiatry, 49, 13
- Taylor J.L., 1987, Psychopharmacology: the third generation of progress.
- Greenblatt D.J., 1986, Psychopharmacol Bull, 22, 416
- Ellinwood E.H., 1987, Psychopharmacol Ser, 3, 77
- Lucki I., 1986, Psychopharmacol Bull, 22, 424
- Annable L., 1989, VIII World Congress of Psychiatry, Book of Abstracts, 422, 116
- Hyman S.E., 1988, Manual of psychiatric emergencies, second edition.
- Klotz U., 1980, Progress in pharmacology, volume 3, no. 3.
Cited by
(2004) · PubMed · Cited by 296
Self-citationAcute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Self-citationDiazepam in the Treatment of Moderate to Severe Alcohol Withdrawal
Weintraub, S. J. (2017) · CNS Drugs · doi:10.1007/s40263-016-0403-y · Cited by 96
Metabolism of Anxiolytics and Hypnotics: Benzodiazepines, Buspirone, Zoplicone, and Zolpidem
Chouinard, G., Lefko-Singh, K., & Teboul, E. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006943009192 · Cited by 87
“1 Portions of this review were taken from a previous paper (Teboul and Chouinard, 1990) with permission from the authors and the Canadian Psychiatric Association.”
BackgroundSelf-citationCloos, J.-M., Bocquet, V., Rolland-Portal, I., Koch, P., & Chouinard, G. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000434755 · Cited by 57
Self-citation
Metadata
- Authors
- Teboul, E., & Chouinard, G.
- Affiliations
- McGill University (CA)
- Institut universitaire en santé mentale de Montréal (CA)
- ORCID
- Teboul, Eric
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 1990-11
- Volume
- 35
- Issue
- 8
- Pages
- 700-710
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- OpenAlex
- W92356027
- Semantic Scholar
- 3b7d6c6a6ebebdd978c20f4739691ab758cf52e3
- Cited by
- 28
- References
- 68
- Citations by year
- 2026: 1 · 2024: 1 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 2 · 2013: 1
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- benzodiazepines, drug selection, pharmacokinetics, plasma concentration, duration of action, drug accumulation, sedation, cognitive impairment, anxiolytic effects, drug metabolism
- MeSH terms
- Anxiety Disorders, Benzodiazepines, Brain, Humans, Sleep Initiation and Maintenance Disorders, Membrane Proteins, Synaptic Transmission, Receptors, GABA-A, Anti-Anxiety Agents, Chloride Channels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Guide to Benzodiazepine Selection. Part I: Pharmacological Aspects *. https://app.cochat.ai/papers/10.1177/070674379003500811
- The paper
- Teboul, E., & Chouinard, G. (1990). A Guide to Benzodiazepine Selection. Part I: Pharmacological Aspects *. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674379003500811
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.